tiprankstipranks

Alto Neuroscience expects cash balance to support operations into 2027

As of September 30, 2024 the Company had cash, cash equivalents, and restricted cash of approximately $182 million. The Company expects its cash balance to support planned operations into 2027.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue